A phase I trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone in combination with gemcitabine for patients with advanced cancer

被引:0
作者
Yun Yen
Kim Margolin
James Doroshow
Mayer Fishman
Bonny Johnson
Caroline Clairmont
Dan Sullivan
Mario Sznol
机构
[1] City of Hope Comprehensive Cancer Center,
[2] Moffitt Cancer Center,undefined
[3] Vion Pharmaceuticals,undefined
[4] Inc.,undefined
来源
Cancer Chemotherapy and Pharmacology | 2004年 / 54卷
关键词
Clinical trial; Phase I; Ribonucleotide reductase; 3-Aminopyridine-2-carboxaldehyde thiosemicarbazone; Gemcitabine; Cancer;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:331 / 342
页数:11
相关论文
共 53 条
  • [1] Abbruzzese undefined(1991)undefined J Clin Oncol 9 491-undefined
  • [2] Bentur undefined(1991)undefined Drug Saf 6 37-undefined
  • [3] Bergman undefined(2002)undefined Drug Resist Updat 5 19-undefined
  • [4] Bhalla undefined(1991)undefined Blood 78 2937-undefined
  • [5] Bokemeyer undefined(1999)undefined J Clin Oncol 17 512-undefined
  • [6] Burris undefined(1997)undefined J Clin Oncol 15 2403-undefined
  • [7] Cardenal undefined(1999)undefined J Clin Oncol 17 12-undefined
  • [8] Chen undefined(2002)undefined Eur J Cancer 38 S26-undefined
  • [9] Coleman undefined(1996)undefined Drug Saf 14 394-undefined
  • [10] Colly undefined(1992)undefined Ann Hematol 65 26-undefined